在人体扩张性心肌病中,瘤亡因子-α转化酶和瘤亡因子-α在人体扩张性心肌病中
M Satoh1, M Nakamura, H Saitoh
1Second Department of Internal Medicine, Iwate Medical University School of Medicine, Iwate, Japan. staohm@iwate-med.ac.jp
Circulation
|June 29, 1999
概括
瘤坏死因子-α转化酶 (TACE) 表达的增加与扩大心肌病 (DCM) 中瘤坏死因子-α (TNF-alpha) 水平的提高有关. 这种关联与DCM更严重的临床指标相关.
科学领域:
- 心脏病学 心脏病学
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 瘤坏死因子-α (TNF-α) 与扩张性心肌病 (DCM) 的病原发生有关.
- TNF-α转化酶 (TACE) 将TNF-α前体加工成其成熟的形式.
- 在DCM中TACE在心肌TNF-alpha产生中的作用尚未完全理解.
研究的目的:
- 在DCM患者的心肌中研究TACE和TNF-alpha表达.
- 确定TACE和TNF-α水平与DCM临床严重程度之间的关系.
主要方法:
- 来自30名DCM患者和5名对照组的内心肌组织样本.
- 实时定量逆转录酶-聚合酶连锁反应对mRNA水平.
- 蛋白质表达的免疫组织化学分析.
主要成果:
- 与对照组相比,DCM患者的TNF-alpha和TACE mRNA都显著增加.
- 在TNF-alpha和TACE mRNA水平之间观察到强烈的正相关性 (r=0.779).
- 增加TACE和TNF-alpha表达与左心室高端缩直径和左心室下部喷射率相关.
结论:
- 心肌TACE表达升高与DCM中心肌TNF-alpha表达升高有关.
- 这种关联在mRNA和蛋白质水平上都很明显.
- 这些发现表明TACE在临床高级DCM的进展中起着作用.
相关概念视频
The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...


